Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Macdougall

Showing results (271-280 of 293) with videos related to

Pageof 30
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 21, 2014
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)Iain C Macdougall, Nicole Casadevall, Francesco Locatelli, et al.
Kidney International|March 3, 2023
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney diseaseKirsten L Johansen, Alexander R Cobitz, Ajay K Singh, et al.
Nephron. Clinical Practice|December 15, 2010
An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO studyAngel L M de Francisco, Joseph Kim, Stefan D Anker, et al.
Journal of General Internal Medicine|June 14, 2012
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Karen M Starko, Henrik S Thomsen, et al.
Kidney360|April 4, 2022
Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL TrialPatrick B Mark, Pardeep S Jhund, Matthew R Walters, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2021
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trialAjay K Singh, Allison Blackorby, Borut Cizman, et al.
Clinical Kidney Journal|May 7, 2021
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trialSharlene A Greenwood, Pelagia Koufaki, Jamie Macdonald, et al.
The Lancet. Oncology|December 3, 2014
Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Pageof 30

Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 21, 2014
Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)Iain C Macdougall, Nicole Casadevall, Francesco Locatelli, et al.
Kidney International|March 3, 2023
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney diseaseKirsten L Johansen, Alexander R Cobitz, Ajay K Singh, et al.
Nephron. Clinical Practice|December 15, 2010
An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO studyAngel L M de Francisco, Joseph Kim, Stefan D Anker, et al.
Journal of General Internal Medicine|June 14, 2012
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR)Charles L Bennett, Karen M Starko, Henrik S Thomsen, et al.
Kidney360|April 4, 2022
Stroke in Hemodialysis Patients Randomized to Different Intravenous Iron Strategies: A Prespecified Analysis from the PIVOTAL TrialPatrick B Mark, Pardeep S Jhund, Matthew R Walters, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2021
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trialAjay K Singh, Allison Blackorby, Borut Cizman, et al.
Clinical Kidney Journal|May 7, 2021
The PrEscription of intraDialytic exercise to improve quAlity of Life in patients with chronic kidney disease trial: study design and baseline data for a multicentre randomized controlled trialSharlene A Greenwood, Pelagia Koufaki, Jamie Macdonald, et al.
The Lancet. Oncology|December 3, 2014
Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Kidney International Reports|August 13, 2021
Randomized Trial-PrEscription of intraDialytic exercise to improve quAlity of Life in Patients Receiving HemodialysisSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Health Technology Assessment (Winchester, England)|June 22, 2021
Exercise programme to improve quality of life for patients with end-stage kidney disease receiving haemodialysis: the PEDAL RCTSharlene A Greenwood, Pelagia Koufaki, Jamie H Macdonald, et al.
Pageof 30